CCN1 and rheumatoid arthritis: Serological levels of Cyr61 were remarkably higher in 177 RA patients compared to healthy controls (median [IQR] 211.57 [140.66–319.01] vs. 37.24 [22.82–56.16], P <  0.001) (Fig. 1a).